Role of Sirt3 in Aging and Caloric Restriction

Sirt3 在衰老和热量限制中的作用

基本信息

  • 批准号:
    8313913
  • 负责人:
  • 金额:
    $ 30.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-15 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Caloric Restriction (CR) is the only well-established protocol in mammals that consistently increases lifespan and delays age-related physiological declines. The recent finding that the health benefits of CR apply to rhesus monkeys has increased interest in developing interventions that can mimic the health benefits of CR. However, the molecular basis of the CR effects in aging is poorly understood. We and others have postulated that a profound "metabolic reprogramming" underlies the health benefits of CR. Recent studies suggest that the mitochondrial sirtuin Sirt3 plays a major role in mitochondrial metabolic control, and we have shown that the ability of CR to prevent age-related hearing loss is completely dependent on Sirt3. Based on these and other observations, our central hypothesis is that Sirt3 mediated deacetylation of key metabolic targets in response to CR increases resistance to oxidative stress and as a consequence prevents age-related mitochondrial dysfunction. Within this application we propose to extensively and mechanistically investigate one of the major processes underlying the effects of CR at the organismal level, the mitochondrial adaptations in response to reduced caloric intake. The proposed studies will address the effects of Sirt3-mediated mitochondrial adaptations in response to CR at the biochemical level through the analysis of Sirt3 targets in mitochondria, at the cellular level through the analysis of age-related mitochondrial dysfunction, and at the tissue-specific level through cardiac and skeletal muscle functional assays of aged animals. We will also determine if the ability of CR to increase lifespan and prevent age-related pathology requires Sirt3. Results from the study will provide a detailed molecular understanding of mitochondrial adaptation to CR and the role of sirtuins in these pathways; Knowledge of the molecular mechanisms and key pathways regulated has potential for significantly improving health outcomes through the development of novel therapeutics that specifically target these pathways.
描述(由申请人提供):热量限制(CR)是哺乳动物中唯一成熟的方案,可以持续延长寿命并延缓与年龄相关的生理衰退。最近发现 CR 对健康的益处适用于恒河猴,这增加了人们对开发可以模仿 CR 的健康益处的干预措施的兴趣。然而,人们对 CR 衰老效应的分子基础知之甚少。我们和其他人推测,CR 的健康益处背后是深​​刻的“代谢重编程”。最近的研究表明,线粒体sirtuin Sirt3在线粒体代谢控制中发挥着重要作用,并且我们已经证明CR预防年龄相关性听力损失的能力完全依赖于Sirt3。基于这些和其他观察结果,我们的中心假设是 Sirt3 介导 CR 响应的关键代谢靶标的脱乙酰化增加了对氧化应激的抵抗力,从而防止了与年龄相关的线粒体功能障碍。在此应用中,我们建议广泛和机械地研究 CR 在有机体水平上影响的主要过程之一,即线粒体对热量摄入减少的适应。拟议的研究将通过分析线粒体中的 Sirt3 靶标,在生化水平上解决 Sirt3 介导的线粒体适应对 CR 的影响;在细胞水平上,通过分析与年龄相关的线粒体功能障碍;在组织特异性水平上,通过老年动物的心脏和骨骼肌功能测定来解决。我们还将确定 CR 延长寿命和预防年龄相关病理的能力是否需要 Sirt3。该研究的结果将为线粒体对 CR 的适应以及去乙酰化酶在这些途径中的作用提供详细的分子理解;了解所调节的分子机制和关键途径有可能通过开发专门针对这些途径的新型疗法来显着改善健康结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M DENU其他文献

JOHN M DENU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M DENU', 18)}}的其他基金

Dynamics and molecular mechanisms linking metabolism and the epigenome
连接代谢和表观基因组的动力学和分子机制
  • 批准号:
    10624003
  • 财政年份:
    2023
  • 资助金额:
    $ 30.52万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10211950
  • 财政年份:
    2021
  • 资助金额:
    $ 30.52万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10434846
  • 财政年份:
    2021
  • 资助金额:
    $ 30.52万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10640272
  • 财政年份:
    2021
  • 资助金额:
    $ 30.52万
  • 项目类别:
Linking mitochondrial variation and lifespan amongst five species of Rodentia
将五种啮齿目动物的线粒体变异与寿命联系起来
  • 批准号:
    9077372
  • 财政年份:
    2016
  • 资助金额:
    $ 30.52万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8706746
  • 财政年份:
    2011
  • 资助金额:
    $ 30.52万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8512636
  • 财政年份:
    2011
  • 资助金额:
    $ 30.52万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8025259
  • 财政年份:
    2011
  • 资助金额:
    $ 30.52万
  • 项目类别:
Reversible Protein Acetylation and Chromatin Function
可逆蛋白质乙酰化和染色质功能
  • 批准号:
    8005210
  • 财政年份:
    2010
  • 资助金额:
    $ 30.52万
  • 项目类别:
SIRTUIN PROTEIN-HISTON DEACETYLASE STUDY
Sirtuin 蛋白-组蛋白去乙酰化酶研究
  • 批准号:
    7954658
  • 财政年份:
    2009
  • 资助金额:
    $ 30.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了